Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-12-16 5:16 pm Purchase |
2021-12-14 | 13G | Cidara Therapeutics, Inc. CDTX |
BIOTECHNOLOGY VALUE FUND L P | 343,056 10.300% |
119,982 (+53.79%) |
Filing History |
| 2021-10-14 5:12 pm Purchase |
2021-10-13 | 13G | Cidara Therapeutics, Inc. CDTX |
Point72 Asset Management, L.P. | 210,000 6.300% |
210,000 (New Position) |
Filing History |
| 2021-08-11 7:27 pm Sale |
2021-08-03 | 13D | Cidara Therapeutics, Inc. CDTX |
INTERWEST PARTNERS X LP | 45,187 1.900% |
-22,654 (-33.39%) |
Filing History |
| 2021-03-05 7:26 pm Purchase |
2021-02-25 | 13G | Cidara Therapeutics, Inc. CDTX |
LYTTON LAURENCE W | 167,020 7.000% |
30,666 (+22.49%) |
Filing History |
| 2021-03-05 4:55 pm Purchase |
2021-02-25 | 13G | Cidara Therapeutics, Inc. CDTX |
LYTTON LAURENCE W | 136,354 5.700% |
136,354 (New Position) |
Filing History |
| 2021-02-16 11:39 am Sale |
2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
5AM VENTURES III L.P. | 100,326 4.600% |
-450 (-0.45%) |
Filing History |
| 2021-02-12 5:01 pm Sale |
2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Stonepine Capital Management, LLC | 0 0.000% |
-102,702 (Position Closed) |
Filing History |
| 2021-02-12 4:17 pm Purchase |
2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
BB BIOTECH AG | 141,125 6.400% |
26,361 (+22.97%) |
Filing History |
| 2021-02-12 4:06 pm Purchase |
2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
BIOTECHNOLOGY VALUE FUND L P | 223,075 9.990% |
54,637 (+32.44%) |
Filing History |
| 2021-02-12 1:51 pm Purchase |
2020-12-31 | 13G | Cidara Therapeutics, Inc. CDTX |
Omega Fund V L.P. | 162,762 7.200% |
18,237 (+12.62%) |
Filing History |